pentacyanoferrate (ii) has been researched along with pyrazinamide in 1 studies
| Studies (pentacyanoferrate (ii)) | Trials (pentacyanoferrate (ii)) | Recent Studies (post-2010) (pentacyanoferrate (ii)) | Studies (pyrazinamide) | Trials (pyrazinamide) | Recent Studies (post-2010) (pyrazinamide) |
|---|---|---|---|---|---|
| 11 | 0 | 5 | 3,626 | 320 | 1,113 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Abbadi, BL; Bernardes-Génisson, V; Bizarro, CV; Carvalho, EM; Chauvin, R; de Freitas Paulo, T; de Morais Campos, R; do Nascimento, NRF; Ferreira, TLA; Lopes, LGF; Macchi, FS; Saquet, AS; Sousa, EHS | 1 |
1 other study(ies) available for pentacyanoferrate (ii) and pyrazinamide
| Article | Year |
|---|---|
Pentacyanoferrate(II) complex of pyridine-4- and pyrazine-2-hydroxamic acid as source of HNO: investigation of anti-tubercular and vasodilation activities.
Topics: Amidohydrolases; Antitubercular Agents; Coordination Complexes; Drug Discovery; Electron Spin Resonance Spectroscopy; Ferrous Compounds; Hydrogen Peroxide; Hydroxamic Acids; Iron; Ligands; Mycobacterium tuberculosis; Nitrogen Oxides; Oxidation-Reduction; Pyrazinamide; Vasodilation | 2020 |